查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587160

梭菌疫苗市场：依动物类型、通路划分 - 全球预测 2025-2030

Clostridium Vaccine Market by Animal Type (Bovine, Ovine, Poultry), Distribution Channel (Hospitals, Veterinary Clinics, Veterinary Research Institute) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年梭菌疫苗市值为5.3663亿美元，预计到2024年将达到5.7398亿美元，复合年增长率为7.05%，到2030年将达到8.6482亿美元。

梭菌疫苗市场包括梭菌细菌引起的疾病的疫苗，例如破伤风、肉毒桿菌和困难梭状芽孢桿菌传染病。对梭菌疫苗的需求是显而易见的，因为它们在预防严重且常常危及生命的疾病方面发挥着重要作用。其用途包括保护处于危险中的人，例如在医疗保健机构或正在接受手术或某些治疗的人，以及应对社区中的集体爆发。最终用途广泛，包括医院、诊所和药品经销商。人们对疫苗接种需求的认识不断提高、梭状芽孢桿菌相关疾病发病率上升以及促进新型疫苗开发的生物技术进步都影响着市场开拓。此外，疫苗开发的监管激励措施也支持了成长前景。机会在于提高新兴市场的疫苗接种覆盖率，这些市场拥有发达的医疗系统和梭菌疾病的高负担。研究包括利用政府间伙伴关係关係进行大规模免疫计划，以及投资下一代疫苗研究，以解决多系统功效和延长免疫持续时间的问题。然而，疫苗犹豫、严格的监管要求以及生物製药製造的复杂性等因素正在阻碍市场成长。此外，与研发相关的高成本以及对低温运输物流的需求也是障碍。多系统疫苗、改进的佐剂以及无针注射和口服疫苗等新的给药系统等创新为业务成长提供了有希望的途径。这些创新可以提高疗效、减少副作用并提高依从性。竞争考察表明，市场竞争激烈、技术进步迅速，要求企业专注于策略联盟和持续产品改进以保持竞争力。总体而言，该市场具有巨大的成长潜力，特别是透过策略创新和在服务不足地区的扩张。

主要市场统计
基准年[2023] 53663万美元
预测年份 [2024] 57398万美元
预测年份 [2030] 86482万美元
复合年增长率（%） 7.05%

市场动态：揭示快速发展的梭菌疫苗市场的关键市场洞察

供需的动态交互作用正在改变梭菌疫苗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 羊和牛感染疾病病例增加
    • 牲畜保健意识不断增强
    • 人类对肉类和奶类的需求量大
  • 市场限制因素
    • 副作用的风险
  • 市场机会
    • 加大畜牧业投资力度
    • 新兴国家兽医服务的增加
  • 市场挑战
    • 低收入国家的动物健康意识和支出有限

波特五力：开拓梭菌疫苗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解梭菌疫苗市场的外部影响

外部宏观环境因素在塑造梭菌疫苗市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解梭菌疫苗市场的竞争状况

对梭菌疫苗市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵式梭菌疫苗市场供应商的绩效评估

FPNV 定位矩阵是评估梭菌疫苗市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了梭菌疫苗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，梭菌疫苗市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 羊和牛的感染病例增加
      • 提高牲畜保健意识
      • 对人肉和牛奶的高需求
    • 抑制因素
      • 副作用的风险
    • 机会
      • 加大畜牧业投资力度
      • 扩大新兴国家的兽医护理服务
    • 任务
      • 低收入国家对动物健康的认知与支出较低
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依动物类型分類的梭菌疫苗市场

  • 牛
  • 羊
  • 家禽
  • 猪

第七章梭菌疫苗市场：依通路分类

  • 医院
  • 兽医诊所
  • 兽医研究所

第八章美洲梭菌疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区梭菌疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲梭菌疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Arko Labs
  • Bayer AG
  • Bimeda, Inc.
  • Boehringer Ingelheim International GmbH
  • CH Boehringer Sohn AG & Co. KG
  • CanFel Therapeutics
  • CEVA Logistics
  • Ceva Sante Animale
  • Colorado Serum Company
  • Eli Lilly and Company
  • Hygieia Biological Laboratories
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Virbac Corporation
Product Code: MRR-4311CE1A33B2

The Clostridium Vaccine Market was valued at USD 536.63 million in 2023, expected to reach USD 573.98 million in 2024, and is projected to grow at a CAGR of 7.05%, to USD 864.82 million by 2030.

The Clostridium Vaccine market encompasses vaccines targeting diseases caused by Clostridium bacteria, such as tetanus, botulism, and Clostridium difficile infections. The necessity of Clostridium vaccines is underscored by their critical role in preventing severe and often life-threatening conditions. Their application includes protecting populations at risk, like individuals in healthcare settings or those undergoing surgeries and certain medical treatments, and addressing outbreaks in communities. The end-use scope spans hospitals, clinics, and pharmaceutical distributors. Market growth is influenced by increasing awareness of the need for vaccination, rising incidences of Clostridium-related diseases, and advances in biotechnology facilitating novel vaccine development. Moreover, regulatory incentives for vaccine development bolster growth prospects. Opportunities lie in expanding vaccine coverage in emerging markets where healthcare systems are developing, and there is a high burden of Clostridium-related diseases. Recommendations include leveraging governmental partnerships for mass immunization programs and investing in next-generation vaccine research addressing multi-strain effectiveness and longer immunity duration. However, market growth is challenged by factors like vaccine hesitancy, stringent regulatory requirements, and production complexities related to biological products. Additionally, the high cost associated with R&D, and the need for cold chain logistics, pose obstacles. Innovations in multi-strain vaccines, improved adjuvants, and novel delivery systems, such as needle-free injections or oral vaccines, represent promising business growth avenues. These innovations can enhance efficacy, reduce side effects, and improve compliance. Insights into the market suggest it is characterized by high competition and rapid technological advancements, requiring companies to focus on strategic collaborations and continuous product improvement to maintain a competitive edge. Overall, this market presents substantial growth potential, especially through strategic innovation and expansion in underserved regions.

KEY MARKET STATISTICS
Base Year [2023] USD 536.63 million
Estimated Year [2024] USD 573.98 million
Forecast Year [2030] USD 864.82 million
CAGR (%) 7.05%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clostridium Vaccine Market

The Clostridium Vaccine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising infection cases among sheep and cattle
    • Increasing awareness for livestock healthcare
    • High demand for meat and milk by humans
  • Market Restraints
    • Risk of side effects
  • Market Opportunities
    • Rising investment in livestock business
    • Increasing veterinary care services across developing countries
  • Market Challenges
    • Limited animal health awareness and expenditure on low income economies

Porter's Five Forces: A Strategic Tool for Navigating the Clostridium Vaccine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clostridium Vaccine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clostridium Vaccine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clostridium Vaccine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clostridium Vaccine Market

A detailed market share analysis in the Clostridium Vaccine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clostridium Vaccine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clostridium Vaccine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clostridium Vaccine Market

A strategic analysis of the Clostridium Vaccine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clostridium Vaccine Market, highlighting leading vendors and their innovative profiles. These include Arko Labs, Bayer AG, Bimeda, Inc., Boehringer Ingelheim International GmbH, C.H. Boehringer Sohn AG & Co. KG, CanFel Therapeutics, CEVA Logistics, Ceva Sante Animale, Colorado Serum Company, Eli Lilly and Company, Hygieia Biological Laboratories, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., and Virbac Corporation.

Market Segmentation & Coverage

This research report categorizes the Clostridium Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Animal Type, market is studied across Bovine, Ovine, Poultry, and Swine.
  • Based on Distribution Channel, market is studied across Hospitals, Veterinary Clinics, and Veterinary Research Institute.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising infection cases among sheep and cattle
      • 5.1.1.2. Increasing awareness for livestock healthcare
      • 5.1.1.3. High demand for meat and milk by humans
    • 5.1.2. Restraints
      • 5.1.2.1. Risk of side effects
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising investment in livestock business
      • 5.1.3.2. Increasing veterinary care services across developing countries
    • 5.1.4. Challenges
      • 5.1.4.1. Limited animal health awareness and expenditure on low income economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clostridium Vaccine Market, by Animal Type

  • 6.1. Introduction
  • 6.2. Bovine
  • 6.3. Ovine
  • 6.4. Poultry
  • 6.5. Swine

7. Clostridium Vaccine Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Veterinary Clinics
  • 7.4. Veterinary Research Institute

8. Americas Clostridium Vaccine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Clostridium Vaccine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Clostridium Vaccine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Arko Labs
  • 2. Bayer AG
  • 3. Bimeda, Inc.
  • 4. Boehringer Ingelheim International GmbH
  • 5. C.H. Boehringer Sohn AG & Co. KG
  • 6. CanFel Therapeutics
  • 7. CEVA Logistics
  • 8. Ceva Sante Animale
  • 9. Colorado Serum Company
  • 10. Eli Lilly and Company
  • 11. Hygieia Biological Laboratories
  • 12. Merck & Co., Inc.
  • 13. Pfizer Inc.
  • 14. Sanofi S.A.
  • 15. Virbac Corporation

LIST OF FIGURES

  • FIGURE 1. CLOSTRIDIUM VACCINE MARKET RESEARCH PROCESS
  • FIGURE 2. CLOSTRIDIUM VACCINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CLOSTRIDIUM VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CLOSTRIDIUM VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CLOSTRIDIUM VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CLOSTRIDIUM VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CLOSTRIDIUM VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CLOSTRIDIUM VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CLOSTRIDIUM VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CLOSTRIDIUM VACCINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLOSTRIDIUM VACCINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLOSTRIDIUM VACCINE MARKET DYNAMICS
  • TABLE 7. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY OVINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLOSTRIDIUM VACCINE MARKET SIZE, BY VETERINARY RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CLOSTRIDIUM VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES CLOSTRIDIUM VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC CLOSTRIDIUM VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM CLOSTRIDIUM VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM CLOSTRIDIUM VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. CLOSTRIDIUM VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. CLOSTRIDIUM VACCINE MARKET, FPNV POSITIONING MATRIX, 2023